Herena Eixarch

NLRP3 inflammasome as prognostic factor and therapeutic target in primary progressive multiple sclerosis patients

Sunny Malhotra, Carme Costa, Herena Eixarch et al. · Brain · 2020 · 127 citations · Full text

Immunology, Immune Regulation, Pathology +21

Neurofilament light chain level is a weak risk factor for the development of MS

Georgina Arrambide, Carmen Espejo, Herena Eixarch et al. · Neurology · 2016 · 105 citations · Full text

GDP- <scp>l</scp> -fucose synthase is a CD4 ⁺ T cell–specific autoantigen in DRB3*02:02 patients with multiple sclerosis

Raquel Planas, Radleigh G. Santos, Paula Tomas-Ojer et al. · Science Translational Medicine · 2018 · 98 citations

Hematopoietic gene therapy restores thymidine phosphorylase activity in a cell culture and a murine model of MNGIE

Javier Torres‐Torronteras, Alberto Zafra‐Gómez, Herena Eixarch et al. · Gene Therapy · 2011 · 58 citations · Full text

Chromatin, Genetics, Hematopoietic Gene Therapy +8

Expression of semaphorin 3A, semaphorin 7A and their receptors in multiple sclerosis lesions

Carme Costa, Elena Martínez‐Sáez, Ana Gutiérrez-Franco et al. · Multiple Sclerosis Journal · 2015 · 51 citations